Rockwell Medical (RMTI) Liabilities and Shareholders Equity (2010 - 2026)

Rockwell Medical has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $57.4 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 6.42% year-over-year to $57.4 million; the trailing twelve-month figure through Mar 2026 stood at $224.7 million (up 0.63% YoY), and the FY2025 full-year result was $57.1 million, down 3.48% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $57.4 million, roughly flat from $57.1 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $59.2 million in Q4 2024, with the low at $37.4 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $51.7 million across 5 years, with a median of $53.0 million in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity sank 46.1% — and 2024, when it jumped 39.41%.
• Rockwell Medical's Liabilities and Shareholders Equity stood at $46.6 million in 2022, then gained by 11.88% to $52.2 million in 2023, then increased by 13.48% to $59.2 million in 2024, then decreased by 3.48% to $57.1 million in 2025, then gained by 0.49% to $57.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $57.4 million (Q1 2026), $57.1 million (Q4 2025), and $57.5 million (Q3 2025), per Business Quant data.